Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 46 | 0 | 6 | 0 | €68.50 | €77.41 | 13.013% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | €66.00 | €84.73 | 28.376% |
| Cytokinetics Inc. | 30 | 1 | 1 | 0 | €50.00 | €84.22 | 68.446% |
| R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.40 | €17.21 | 38.811% |
| Addus Homecare Corp. | 23 | 1 | 4 | 0 | €122.00 | €122.73 | 0.597% |
| EyePoint Pharmaceuticals Inc. | 21 | 1 | 2 | 0 | €8.21 | €27.91 | 239.903% |
| TG Therapeutics Inc. | 20 | 1 | 2 | 0 | €20.99 | €31.12 | 48.278% |
| Krystal Biotech | 19 | 0 | 3 | 0 | €183.50 | €186.59 | 1.684% |
| G1 Therapeutics | 19 | 1 | 0 | 0 | €6.41 | €11.09 | 73.133% |
| Esperion Therapeutis.Inc. | 18 | 1 | 4 | 0 | €1.53 | €9.27 | 508.052% |
| Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | €31.00 | €36.87 | 18.929% |
| Verastem Inc. | 16 | 0 | 4 | 0 | €2.18 | €16.20 | 643.271% |
| Geron Corp. | 16 | 0 | 1 | 0 | €4.06 | €5.54 | 36.252% |
| Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | €20.11 | €60.12 | 198.948% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €44.80 | €46.51 | 3.806% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | €18.34 | €26.64 | 45.293% |
| MacroGenics Inc. | 14 | 0 | 3 | 0 | €3.06 | €12.31 | 301.599% |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | €19.10 | €78.70 | 312.045% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Staar Surgical Co. | 13 | 1 | 1 | 0 | €29.30 | €47.59 | 62.435% |
| Adverum Biotechnologies Inc. | 11 | 0 | 2 | 0 | €1.38 | €23.35 | 1591.667% |
| AnaptysBio Inc | 12 | 1 | 3 | 0 | €32.60 | €48.09 | 47.507% |
| Ocular Therapeutix Inc. | 15 | 4 | 1 | 0 | €8.09 | €13.09 | 61.759% |
| Pro-Dex Inc. | 10 | 0 | 0 | 0 | €18.40 | - | - |
| Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | €1.78 | €4.63 | 160.022% |